AMEX:LABU is about to take off, one of the sectors most affected by the reduction in earnings due to the decline in medicine sales during the pandemic. However, it shows signs of stabilization, at least a 17% and a 35% in the foreseeable future with two falling wedges. Remember cyclicals in a overload market.
Axsome Therapeutics Inc (AXSM) I have been in this spot trade since $50.77. We are now at $72.93. I have much higher targets as you can see from the chart. This is a long term trade looking to hold for 12 – 24 months however feel that something is going to happen within 6 – 12 months based on the chart. - Forming pennant on chart and RSI. Potential for...
If it holds support, it'll take off and head towards the top end of the range. Check out the crazy Call Options volume for the 8/18 $7.5 Strike Price... over 23,000 for this little unknown Pharma company. Somebody knows something... don't you think? Mersana Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of...
HROW with a nice impulsive, 5-wave move off the low. HROW needs to hold the 0.618 retracement ($18.75) on this pull back, followed by a rally above the $19.95 local peak set today for further confirmation. Very bullish on the long-term prospects of this ticker.
This strategy dissects the dual nature of big pharmaceutical firms like Johnson & Johnson, Pfizer, Moderna, and Merck & Co viewed through base Fibonacci Extension Clustering. Despite big pharma's significant contributions to healthcare, these firms have benefited from questionable practices, including price manipulation and exploiting addictions . Price...
VRPX was on a downtrend from mid-February into a reversal the beginning of May. VRPX beat earnings up still has no cash flow which is very common in this subsector. VRPX is priced on the potential of future earnings. The short and long-moving averages ratio shows bullish momentum also shows strength with an upper Bollinger Band "walk". Price has climbed...
Stock Aridis Pharmaceuticals Inc. NASDAQ:ARDS (low float stock)
MGRX a recent IPO produces a med for erectile dysfunction without FDA approval; They are basically selling a generic version of an approved medication and bypassing the patent protections and betting they will fly under the regulator radar apparatus. As might be expeted this recent nano-IPO is highlly volatile. Play with it only if you have the requisite...
- Big initial move right of out the gate - ~1 month consolidation - Confluence of MAs - New Momentum - High ADR - Pharma
NASDAQ:BBIO tight action. Pharma has been popping as of late - hopefully that continues. Anticipation set-up.
Tight Action on $UNCY. Massive run up on big volume and holding level.
$AUPH AUPH inside days after good run up and decent beat. Liquid and increasing institutional interest.
AmerisourceBergen is a pharma company with superb growth and financials. Healthcare sector has been deeply sold off. This is a strong trending stock on the weekly (see 52 week EMA Red line). I look to add a small starter position at 154.46, the Gann Confluence Line. Will add another position should it reach either the 52 Week EMA or a RSI (12) weekly of 39 - 40....
Inv Head and Shoulders formed on Adcock and now the price is above the neckline showing upside to come. 7>21>200 RSI>50 Bullish CONCERNS: This is a very volatile, flimsy and illiquid stock compared to the Blue Chips. I call these unhealthy charts which seldom work well with breakout patterns. Maybe as a Weekly analysis or Monthly will show some more promising...
The technical figure Channel Up can be found in the daily chart in the French company Sanofi S.A. (SAN.pa). Sanofi S.A. is a French multinational pharmaceutical and healthcare company. Sanofi engages in the research and development, manufacturing and marketing of pharmacological products, principally in the prescription market, but the firm also develops...
Hey traders, My weekly trade idea. The daily price is forming a textbook Cup&Handle formation. After the consolidation in the handle phase, the price is ready to go higher. The momentum will push the price and in my opinion, it is headed to test the all-time high in the 180$ area. The Relative Strength Index broke above its trend line and is moving upward to...
The UnitedHealth Group (UNH) hit the Resistance Zone following our last (November 18) signal but as it failed to break through its top, it got rejected: By doing so, the price even broke below the Higher Lows trend-line and the Bullish Megaphone pattern, that were in effect since February 2021. This potentially signals a deceleration on its enormous and...
Hi Traders We can't say much here! As always history has shown us when a new drug goes on the market we have 3 scenarios: 1 we're going up (green path) 2 the medicine is not good we are going down (red path) 3 we don't know what the medicine is like until many people take it let's go sideways (purple path) with all that is happening at the moment we are...